Plain-English translation of NCT07645924 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This research study is testing a new medication called to see if it can effectively treat migraine headaches when you take it during an attack. Researchers will compare how well this medication works compared to a placebo (a pill with no active medicine), and they'll measure how safe and tolerable the treatment is for you.
Many people with frequent migraines need better treatment options that work faster and more reliably. This study is exploring whether this medication could be a helpful new choice for people who experience moderate to severe migraine attacks.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic multiple times to provide information about your migraine history and current health. You will then be randomly assigned to take either the new medication, a different dose of the medication, or a placebo when you have a migraine attack. During the study, you'll use a smartphone app to record details about your migraines and how the treatment works for you. The researchers will monitor your health and safety throughout the study.
AI-generated summary from trial data · Aug 31, 2026 · Not medical advice
United States